Details
Stereochemistry | RACEMIC |
Molecular Formula | C22H25N.ClH |
Molecular Weight | 339.902 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN1CCC(C1C)=C2C3=C(CCC4=C2C=CC=C4)C=CC=C3
InChI
InChIKey=PLJNHZOEOXGWIR-UHFFFAOYSA-N
InChI=1S/C22H25N.ClH/c1-3-23-15-14-19(16(23)2)22-20-10-6-4-8-17(20)12-13-18-9-5-7-11-21(18)22;/h4-11,16H,3,12-15H2,1-2H3;1H
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C22H25N |
Molecular Weight | 303.4406 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
CNS Activity
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Pharmacological study of piroheptine, a new antiparkinson drug. II. Anticholinergic, antihistaminic, and psychopharmacological actions and toxicity. | 1972 Jun |
|
Biperiden and piroheptine do not affect the serum level of zotepine, a new antipsychotic drug. | 1990 Jul |
|
Effects of anticholinergic antiparkinsonian drugs on binding of muscarinic receptor subtypes in rat brain. | 1990 Sep |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:25:18 GMT 2023
by
admin
on
Fri Dec 15 15:25:18 GMT 2023
|
Record UNII |
4ZM573199N
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m8886
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | Merck Index | ||
|
C055566
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
100000125906
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
DTXSID00936870
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
SUB32954
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
32018
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
27844
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106830
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
4ZM573199N
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY | |||
|
16378-22-6
Created by
admin on Fri Dec 15 15:25:18 GMT 2023 , Edited by admin on Fri Dec 15 15:25:18 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |